Aug 05, 2020 Antibodies

Assessing Molecular Point-of-Care Testing and Dried Blood Spot for Hepatitis C Virus Screening in People Who Inject Drugs

Background: Injecting drug use is the primary driver of the hepatitis C virus (HCV) is spread throughout the world, and the World Health Organization (WHO) has identified people who inject drugs (PWID) as a key population for targeted for HCV…

Aug 05, 2020 Antibodies

A case presentation for positive SARS-CoV-2 RNA recurrence in a patient with a history of type 2 diabetes that had recovered from severe COVID-19

Coronavirus disease in 2019 (COVID-19) considered the spread primarily by people who have tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we discuss COVID 19 patients with severe and a history of type 2 diabetes who have…

Aug 05, 2020 Antibodies

[Strategies for infection control in managing critically ill patients with suspected coronavirus disease 2019 in non-designated hospital]

Management of health services for suspected cases in a non-designated hospitalsis be a serious concern in controlling the disease in 2019 coronavirus (COVID-19) epidemic. Because of the complexity of the service provider, large requirements of medical supplies and the possible…

Aug 05, 2020 Antibodies

Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection

Objective: The various ranges of viral RNA shedding duration in patients infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been observed. We aimed to investigate factors associated with prolonged and intermittent viral RNA shedding in a retrospective cohort…